Company / Total Assets
Beam Therapeutics Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.5B
FY2025
5-year range
$1.1B / $1.5B
FY2021-FY2025
Trend
+34.2%
vs FY2024
Sector context
#53 of 214
Health Care
What the data says
Beam Therapeutics Inc.'s total assets of $1.5B is higher than 75% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 7 years, ranging from $156M in FY2019 to $1.5B in FY2025.
Based on SEC 10-K filings.
$1.5B in FY2025 with a 5-year CAGR of +26.8%. Top quartile in the Health Care sector.
Remained stable around $1.5B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- +26.8%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 214This company $1.5B Sector average $7.5B
▼
-80.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +26.8%, indicating consistent growth.
- In FY2025, total assets increased 34.2% year-over-year.
- Ranks #53 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5B | +34.2% |
| FY2024 | $1.1B | -24.4% |
| FY2023 | $1.5B | +8.8% |
| FY2022 | $1.3B | -9.0% |
| FY2021 | $1.5B | +226.4% |
| FY2020 | $451.7M | +189.4% |
| FY2019 | $156.1M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026